Fig. 4
From: CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma
CA916798 activates WEE1/CDK1 axis to promote cell cycle progression
A) Pearson correlation of CA916798 with CDK1 from TCGA_LUAD dataset
B) Western blotting of A549 and PC9 cells with CA916798 knockdown (shCA) vs. shControl (shCtrl)
C) Western blotting of A549 and PC9 cells with CA916798 overexpression (CA) vs. empty vector (Ctrl)
D) Cell cycle distribution measured by flow cytometry in cells treated with 0.1 µM Ro-3306 (CDK1 inhibitor) for 24 h